Researchers found an increase in the proportions of youth who experienced anxiety (7.1% to 10.6%) or depression (3.2% to 4.6%). HealthDay News — From 2016 to 2022, there was an increase in the ...

More than 1 in 7 adults reported carrying medical debt in 2023, and of these, 1 in 3 forwent mental health care in the subsequent year.

The FDA has issued a Complete Response Letter to Telix Pharmaceuticals regarding the NDA for TLX101-CDx for the imaging of gliomas.

Moderately preterm birth is associated with cognitive problems at ages 9 to 10 years, according to a study published online April 14 in JAMA Network Open. Samso ...

An intensive blood pressure reduction intervention is effective for lowering the risk for all-cause dementia among individuals aged 40 years and older with untreated hypertension.

Via decreased negative and increased positive affect pre- and post- positive/relief events, worry led to enhanced positive emotional contrasts.

Hyperactivation of certain brain regions in children and adolescents with ARFID suggest a new neurobiological circuit associated with the disorder.

Metabolic syndrome (MetS) and its individual components are associated with an increased risk for young-onset dementia (YOD).

The prevalence of depression among adolescents and adults aged 12 years and older during 2021 to 2023 had a 60% increase from 2013 to 2014.

HealthDay News — Patients with heart failure experience worsening neuropsychological outcomes over six months, according to a study published online April 8 in Advances in Clinical and Experimental ...

More than 40% of US adults know someone who died by suicide and 5.3% reported suicidal thoughts during the previous 12 months.

The FDA has granted Orphan Drug designation to BA-102 for the treatment of Phelan-McDermid syndrome, a rare neurodevelopmental disorder.